Medicine · 20 Nov 2026
Effects of a 12-week multi-strain probiotics supplementation on circulating endotoxin and antioxidant enzymes among overweight/obese Saudi adults: Randomized, double-blind, placebo-controlled trial
Samira M. AlMalkih-index 2, Hanan A. Alfawaz, Shaun Sabico, Abdullah M. Alnaami, Noura M. Alshiban, Syed D. Hussain, Razi A. Ibrahim, Nasser M. Al-Daghrih-index 74
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Background: Several clinical trials have indicated the favorable effects of probiotics in lowering the risk of chronic diseases such as obesity; however, few of them have explored the potential in altering obesity-related biomarkers, and the present study aimed to fill this gap. Methods: A total of 93 overweight/obese adults (males and females, aged 19–40 years) were recruited at the clinical facility of King Saud University Medical City, Riyadh, Saudi Arabia, between March 2022 and January 2023 in a double-blind, placebo-controlled, randomized clinical trial. In this study, the subjects were randomly assigned to receive 30 × 10 9 colony-forming units HEXBIO ® containing 3 Bifidobacterium and 3 Lactobacillus species (N = 44; 64% subjects) or a placebo containing the same excipients without the live bacterial strains (N = 49; 76% subjects); all subjects consumed the product twice daily for 3 months. Results: At baseline, anthropometric measurements, the liver profile, and antioxidant enzymes did not differ significantly between the probiotic and placebo groups. Following the 12-week intervention, within-group analysis revealed significant increases in the levels of superoxide dismutase (0.06 ± 0.1 vs 0.19 ± 0.29 U/mL; P = .02) and glutathione peroxidase (GPX1; 0.66 ± 0.23 vs 0.76 ± 0.2; P = .01) among all probiotic-supplemented subjects. After stratification by sex, significant favorable changes in superoxide dismutase (0.03 ± 0.04 vs 0.29 ± 0.4; P = .05) and GPX1 (0.66 ± 0.26 vs 0.82 ± 0.18; P = .03) were observed only in the male probiotics group, and between-group comparisons showed a modest but clinically significant difference only in GPX1 in favor of the probiotics group ( P = .04). These changes were not observed in females. No differences were observed in the levels of endotoxins and liver enzymes over time in both groups. Conclusion: The administration of multi-strain probiotic supplements for 3 months, along with dietary intervention, was associated with a modest favorable change in GPX1 levels in males, with no apparent changes in circulating endotoxins or liver enzymes. These findings suggest a potential sex-specific effect of probiotic supplementation on antioxidant defense. However, results should be interpreted cautiously given the modest effect. Adequately powered clinical trials are warranted to confirm these findings.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Nasser M. Al-Daghri has the highest h-index among the authors (74).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (43)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 23 more references
A free account opens the rest of the citing papers and references on every paper’s page.